A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate the safety, feasibility, quality of life, primary caregiver satisfaction, and cost effectiveness of integrated Home Telehealth care versus standard care in a heart failure clinic.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Heart Failure Events Reduction With Remote Monitoring and eHealth Support Investigator Initiated Trial

NCT03663907

Heart Failure

COMPLETED NA

Telemedical Interventional Monitoring in Heart Failure

NCT00543881

Chronic Heart Failure

COMPLETED PHASE3

Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF

NCT05487365

Heart Failure Heart Failure NYHA Class II Heart Failure NYHA Class III +1 more

UNKNOWN NA

Telemedicine in Heart Failure; Treatment, Prognosis and Patient Experience

NCT06237998

Heart Failure

COMPLETED

Protocol of a Pilot Study to Optimize Care for Heart Failure Patients in Primary Care

NCT02905786

Heart Failure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We plan to implement and evaluate a Home Telehealth Care Management System designed to enhance clinical care for congestive heart failure patients who have difficulty with access to care. Unique in this model is that in addition to use of protocol driven interventions (evidence based), the primary care physician is intimately involved in follwo up of patients- with consequent reduction in the fracture of care seen in with attendance in multiple specialty clinics.

In this project, we will evaluate the delivery of care to heart failure patients in Nova Scotia and New Brunswick, with our intervention and the current standard of care, which is the heart failure clinic. Home Telehealth technology will allow patients to be contacted and regularly evaluated in a comprehensive way in their own home, and without the need for a clinic visit. While the Project Team (experienced in heart failure management) will monitor all data, the Family Physician will have first hand access to and right of first treatment when alterations in therapy are needed. This process will be facilitated by the use of protocol driven medical therapy, and delegated medical functions, as well as set-piece education. We hope, with this technology and care plan, to offer the benefits of disease management to this vulnerable patient population while at the same time firmly placing the Family Physician in their central role within the health care system. This program will enable a specific assessment of all aspects of the program, including outcomes, quality of life, professional satisfaction and cost.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Home teleheatlh for heart failure management

Group Type ACTIVE_COMPARATOR

Routine Care in a HF clinic vs Home Telehealth Care for HF

Intervention Type DEVICE

2

Usual care for the management of Heart Failure

Group Type ACTIVE_COMPARATOR

Routine Care in a HF clinic vs Home Telehealth Care for HF

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine Care in a HF clinic vs Home Telehealth Care for HF

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female subject's ≥ 18 years of age with a diagnosis of Heart Failure
2. Subject must reside in either the Province of Nova Scotia or New Brunswick
3. Subject has been hospitalized for heart failure during the past two years or has a known history of heart failure for a minimum of two years.
4. Subject must have a dedicated working telephone line in their primary place of residence.
5. Subject must have a grounded electrical power supply in their primary place of residence.
6. Primary care physician provides their agreement to participate in STARTEL

Exclusion Criteria

1. Inability to understand the English or French language or understand the study and provide informed consent.
2. Absence of a suitable area to conduct the home telehealth visit in the patient's place of residence.
3. Physical impairment, which would prohibit the successful completion of a home telehealth visit, including attachment of the peripheral equipment (BP cuff, ability to stand on a scale, etc).
4. In cases 1 \& 3 only: a live in caregiver whose presence may overcome these limitations may allow the patient to be included in the study, however, only the patient's next of kin or duly appointed guardian (with documentation and with patient assent) may provide informed consent to participate).
5. Subject has a planned cardiac procedure such as open-heart surgery or percutaneous coronary intervention (PCI) within the next 6 months.
6. Subject has had cardiac surgery, percutaneous coronary intervention or a diagnosis of acute myocardial infarction within 1 month before randomization).
7. Condition where existing routine follow up occurs more than once weekly (i.e. hemodialysis, cancer treatment including: chemotherapy/radiation treatment). .
8. Patient is institutionalized (includes chronic care facility)

Eligible Sex

ALL

Accepts Healthy Volunteers

No